This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

CVS Group's buy of The Vet raises competition concerns, says UK CMA

( February 18, 2022, 07:32 GMT | Official Statement) -- MLex Summary: CVS Group’s completed purchase of Quality Pet Care, trading as The Vet, raises competition concerns and could be referred for an in-depth investigation unless CVS offers solutions to remedy them, the UK's Competition and Markets Authority has said. The CMA has found that the merger raises competition concerns in five local areas. This could lead to pet owners facing a worse quality of service, including more limited treatment options, or having to pay higher prices, the CMA said.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login